Biosystems ApS: Financial statements 2023
CVR: 41945729
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Biosystems ApS (CVR 41945729) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 334 and a net result of DKK 2,054 compared with DKK -957 the year before. Equity in the 2023 report amounted to DKK 11,804. The solvency ratio was 43.6%.
- Gross Profit
- DKK 334
- Profit/Loss
- DKK 2,054
- Equity
- DKK 11,804
- Total Assets
- DKK 27,066
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 334 | 2 t. | 12 t. | - |
| 2022 | - | -10 t. | -957 | 10 t. | - |
| 2021 | - | -30 t. | -29 t. | 11 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Biosystems ApS has published its annual report for 2022. Gross profit came to DKK -9,784, and the net result was DKK -957.
About Biosystems ApS
Biosystems ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2020. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The management consists of Jonas Jacob Husmer. The company is owned by Biosystems Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -14,477 and a net result of DKK -10,473 compared with DKK -9,083 the year before. Equity in the 2025 report amounted to DKK -7,752.